Home Ligand Pharmaceuticals Lowered to Hold at Zacks
 

Keywords :   


Ligand Pharmaceuticals Lowered to Hold at Zacks

2015-08-23 17:16:33| Biotech - Topix.net

According to Zacks, "Ligand delivered better-than-expected second-quarter results with the company beating both top- and bottom-line estimates. Ligand's Captisol formulation technology has resulted in partnerships with several leading health care companies like Novartis, Amgen and Pfizer among others that provide the company with funds in the form of milestone and royalty payments.

Tags: hold lowered pharmaceuticals ligand

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
14.1115kg 50mm
14.11ONE PIECE BOX
14.11DAIWA OCEAN STAR 500
14.11fender jhon mayer blackone
14.11 Angel Touch Plus vol.3
14.11Strymon BigSky
14.11
14.11 TOUR B X 2
More »